Reblozyl vs. Revlimid

Are Reblozyl and Revlimid the Same Thing?

Reblozyl (luspatercept-aamt) and Revlimid (lenalidomide) are used to treat anemia associated with different conditions.

Reblozyl is used to treat anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.

Revlimid is used to treat patients with anemia and multiple myeloma. Revlimid is also used in patients with myelodysplastic syndrome and may also be used for other purposes not listed.

Reblozyl is an erythroid maturation agent and Revlimid is a thalidomide analogue.

Side effects of Reblozyl and Revlimid that are similar include headache, joint pain, diarrhea, nausea, and fatigue/tiredness.

Side effects of Reblozyl that are different from Revlimid include bone pain, cough, abdominal pain, dizziness, influenza, high blood pressure (hypertension), high uric acid levels in the blood, and viral upper respiratory tract infection.

Side effects of Revlimid that are different from Reblozyl include constipation, dry or itchy skin, runny or stuffy nose, and muscle pain.

Reblozyl may interact with other medicines.

Revlimid may interact with hormonal birth control.

What Are Possible Side Effects of Reblozyl?

Side effects of Reblozyl include:

  • headache,
  • bone pain,
  • joint pain,
  • fatigue,
  • cough,
  • abdominal pain,
  • diarrhea,
  • dizziness,
  • nausea,
  • influenza,
  • high blood pressure (hypertension),
  • high uric acid levels in the blood,
  • viral upper respiratory tract infection, and
  • cough

What Are Possible Side Effects of Revlimid?

Common side effects of Revlimid include:

  • nausea,
  • diarrhea,
  • constipation,
  • dry or itchy skin,
  • runny or stuffy nose,
  • muscle or joint pain,
  • headache, or
  • tiredness

Serious side effects of Revlimid include:

What Is Reblozyl?

Reblozyl (luspatercept-aamt) is an erythroid maturation agent indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.

What Is Revlimid?

Revlimid (lenalidomide) is a thalidomide analogue indicated for the treatment of patients with anemia and multiple myeloma. Revlimid is also used in patients with myelodysplastic syndrome and may also be used for other purposes not listed.

QUESTION

Sickle cell disease is named after a farming tool. See Answer

What Drugs Interact With Reblozyl?

Reblozyl may interact with other medicines.

Tell your doctor all medications and supplements you use.

What Drugs Interact With Revlimid?

Revlimid may interact with other drugs.

Tell your doctor all medications and supplements you use.

How Should Reblozyl Be Taken?

The recommended starting dose of Reblozyl is 1 mg/kg once every 3 weeks by subcutaneous injection.

How Should Revlimid Be Taken?

The recommended starting dose of Revlimid is 10 mg daily.

SLIDESHOW

Understanding Cancer: Metastasis, Stages of Cancer, and More See Slideshow

From WebMD Logo

Healthy Resources
Featured Centers
Health Solutions From Our Sponsors
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Celgene. Reblozyl Product Information.

https://www.reblozylpro.com/

Celgene. Revlimid Product Information.

www.revlimidhcp.com/?

Health Solutions From Our Sponsors